The Leadership Team at IDRx is responsible for strategic decision-making and guiding the company's vision in developing precision combination therapies for cancer care. This team, composed of experienced professionals across various disciplines, including clinical pharmacology, product development, and biostatistics, collaborates to advance clinical programs, ensure regulatory compliance, and drive innovation in oncology treatments. Their collective expertise helps shape IDRx's research direction and operational strategies to maximize therapeutic impact and patient outcomes.
Alexis Borisy
Co-Founder
David Kerstein
Chief Medical Officer
Debbie Johnson
Vice President Clinical Operat...
Debra L. Mazaik
Vice President, Pharmaceutical...
James Shao
Vice President, Biostatistics
Jessica Anderson Chr...
Chief Development Operations O...
Robert Forrester
Co-Founder & Director
Vivek Kadambi
Senior Advisor
View all